Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection - PubMed (original) (raw)
Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection
C Brander et al. J Clin Invest. 1998.
Abstract
Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A*0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A*0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A*0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A*0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of immunodominant CTL responses present during chronic HIV-1 infection.
Similar articles
- Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T. Schmitt-Haendle M, et al. Viral Immunol. 2005;18(4):627-36. doi: 10.1089/vim.2005.18.627. Viral Immunol. 2005. PMID: 16359229 - Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.
Goulder PJ, Sewell AK, Lalloo DG, Price DA, Whelan JA, Evans J, Taylor GP, Luzzi G, Giangrande P, Phillips RE, McMichael AJ. Goulder PJ, et al. J Exp Med. 1997 Apr 21;185(8):1423-33. doi: 10.1084/jem.185.8.1423. J Exp Med. 1997. PMID: 9126923 Free PMC article. - The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD. Altfeld M, et al. J Virol. 2005 Apr;79(8):5000-5. doi: 10.1128/JVI.79.8.5000-5005.2005. J Virol. 2005. PMID: 15795285 Free PMC article. - Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus.
Rivière Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L. Rivière Y, et al. Res Immunol. 1989 Jan;140(1):110-5; discussion 121. doi: 10.1016/0923-2494(89)90015-1. Res Immunol. 1989. PMID: 2657908 Review. No abstract available. - Why high levels of virus-specific CTL persist in HIV1-infected individuals.
Koup RA, Sullivan JL. Koup RA, et al. Res Immunol. 1989 Jan;140(1):92-5; discussion 118-9. doi: 10.1016/0923-2494(89)90010-2. Res Immunol. 1989. PMID: 2543042 Review. No abstract available.
Cited by
- Current situation in the development of a preventive HIV vaccine.
Alcamí J, Joseph Munné J, Muñoz-Fernández MÁ, Esteban M. Alcamí J, et al. Enferm Infecc Microbiol Clin. 2005 Jul;23:15-24. doi: 10.1016/S0213-005X(05)75157-0. Epub 2009 Jan 6. Enferm Infecc Microbiol Clin. 2005. PMID: 38620211 Free PMC article. - Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells.
Zhou Y, Jadlowsky J, Baiduc C, Klattenhoff AW, Chen Z, Bennett AD, Pumphrey NJ, Jakobsen BK, Riley JL. Zhou Y, et al. PLoS Pathog. 2023 Dec 15;19(12):e1011853. doi: 10.1371/journal.ppat.1011853. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38100526 Free PMC article. - CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection.
Qin K, Boppana S, Du VY, Carlson JM, Yue L, Dilernia DA, Hunter E, Mailliard RB, Mallal SA, Bansal A, Goepfert PA. Qin K, et al. PLoS Pathog. 2019 Aug 9;15(8):e1007970. doi: 10.1371/journal.ppat.1007970. eCollection 2019 Aug. PLoS Pathog. 2019. PMID: 31398241 Free PMC article. - Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
Grossman MA, Hofmann C, Ng HL, Yang OO. Grossman MA, et al. AIDS. 2019 Aug 1;33(10):1565-1574. doi: 10.1097/QAD.0000000000002259. AIDS. 2019. PMID: 31306165 Free PMC article. - Genetic Strategies for HIV Treatment and Prevention.
Falkenhagen A, Joshi S. Falkenhagen A, et al. Mol Ther Nucleic Acids. 2018 Dec 7;13:514-533. doi: 10.1016/j.omtn.2018.09.018. Epub 2018 Sep 29. Mol Ther Nucleic Acids. 2018. PMID: 30388625 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11047-51 - PubMed
- J Virol. 1996 Sep;70(9):5799-806 - PubMed
- J Immunol. 1992 Dec 15;149(12):4060-6 - PubMed
- J Exp Med. 1993 Feb 1;177(2):249-56 - PubMed
- Curr Opin Immunol. 1993 Feb;5(1):35-44 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials